Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
0.9458
+0.0243 (2.64%)
At close: Jun 6, 2025, 4:00 PM
0.9498
+0.0040 (0.42%)
After-hours: Jun 6, 2025, 7:59 PM EDT
Silexion Therapeutics Market Cap
Silexion Therapeutics has a market cap or net worth of $7.96 million as of June 6, 2025. Its market cap has decreased by -87.66% in one year.
Market Cap
7.96M
Enterprise Value
11.26M
1-Year Change
-87.66%
Ranking
Category
Stock Price
0.95
Market Cap Chart
Since April 7, 2021, Silexion Therapeutics's market cap has decreased from $148.55M to $7.96M, a decrease of -94.64%. That is a compound annual growth rate of -50.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 6, 2025 | 7.96M | 146.99% |
| Dec 31, 2024 | 3.22M | -92.33% |
| Dec 21, 2023 | 41.99M | -71.93% |
| Dec 30, 2022 | 149.59M | 4.03% |
| Dec 31, 2021 | 143.80M | -3.20% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 689.98B |
| Johnson & Johnson | 372.34B |
| AbbVie | 336.06B |
| Novo Nordisk | 324.15B |
| UnitedHealth Group | 271.74B |
| Abbott Laboratories | 232.88B |
| Novartis AG | 230.96B |
| AstraZeneca | 225.55B |